JFNIX
Price
$65.89
Change
+$0.35 (+0.53%)
Updated
Aug 1 closing price
Net Assets
4.4B
LHCCX
Price
$17.38
Change
+$0.10 (+0.58%)
Updated
Aug 1 closing price
Net Assets
7.22M
Interact to see
Advertisement

JFNIX vs LHCCX

Header iconJFNIX vs LHCCX Comparison
Open Charts JFNIX vs LHCCXBanner chart's image
Janus Henderson Global Life Sciences I
Price$65.89
Change+$0.35 (+0.53%)
VolumeN/A
Net Assets4.4B
Lord Abbett Health Care C
Price$17.38
Change+$0.10 (+0.58%)
VolumeN/A
Net Assets7.22M
JFNIX vs LHCCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JFNIX vs. LHCCX commentary
Aug 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFNIX is a Buy and LHCCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.4B vs. LHCCX (7.22M). JFNIX pays higher dividends than LHCCX: JFNIX (0.41) vs LHCCX (0.00). JFNIX was incepted earlier than LHCCX: JFNIX (16 years) vs LHCCX (6 years). LHCCX (4.09) is less costly to investors than JFNIX (0.77). LHCCX is a more actively managed with annual turnover of: 88.00 vs. JFNIX (35.00). LHCCX has a lower initial minimum investment than JFNIX: LHCCX (1500) vs JFNIX (2500). LHCCX annual gain was more profitable for investors over the last year : -8.04 vs. JFNIX (-16.57). JFNIX return over 5 years is better than : 3.58 vs. LHCCX (-3.66).
JFNIXLHCCXJFNIX / LHCCX
Total Expense Ratio0.771.7843%
Annual Report Gross Expense Ratio0.774.0919%
Fund Existence16 years6 years-
Gain YTD-3.131-5.54356%
Front LoadN/AN/A-
Min. Initial Investment25001500167%
Min. Initial Investment IRAN/AN/A-
Net Assets4.4B7.22M60,944%
Annual Yield % from dividends0.410.00-
Returns for 1 year-16.57-8.04206%
Returns for 3 years6.973.45202%
Returns for 5 years3.58-3.66-98%
Returns for 10 years5.82N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IOGYX37.280.56
+1.53%
Invesco Gold & Special Minerals R5
PAEIX14.61-0.02
-0.14%
T. Rowe Price Overseas Stock Advisor
CIESX25.70-0.20
-0.77%
Calvert International Equity R6
OSTGX16.07-0.19
-1.17%
Osterweis Opportunity Fund
ZVGNX55.95-1.45
-2.53%
Zevenbergen Genea Investor